Causal relationship between COVID-19, vaccination, and 20 digestive diseases: a comprehensive two-sample Mendelian randomization study.

Publication date: Jun 30, 2025

Sequelae and complications have become a significant concern in the post-pandemic era of Coronavirus disease 2019 (COVID-19). However, it remains unclear whether there is a direct causal relationship between COVID-19 or vaccination and digestive diseases, as existing evidence is ambiguous and controversial. In this study, we investigated the associations between multiple COVID-19 infection phenotypes, vaccination, and 20 common digestive diseases, and explored their causal relationships through extensive Mendelian randomization (MR) analysis. For individuals of European descent, we conducted an extensive two-sample Mendelian randomization (MR) analysis using genome-wide association study (GWAS) data. Six COVID-19 infection (six phenotypes) GWAS datasets and two vaccination (from the UK and Finland) GWAS datasets were used as exposure factors; 20 common digestive diseases were treated as outcome factors, with each disease having two or more GWAS datasets, mostly sourced from the UK Biobank and FinnGene platforms. Single nucleotide polymorphisms (SNPs) associated with the exposures were used as instrumental variables (IVs) to estimate the causal relationship between COVID-19, vaccination, and the 20 digestive diseases. Meta-analysis was conducted to assess the combined causal effect from multiple MR results. MR analysis revealed a causal relationship between COVID-19 and duodenal ulcer (P = 4. 98E-03, OR = 1. 00, 95% CI: 1. 00-1. 00). Additionally, COVID-19 hospitalization was associated with viral hepatitis (P = 4. 94E-02, OR = 1. 10, 95% CI: 1. 00-1. 21), cirrhosis (P = 1. 72E-02, OR = 0. 91, 95% CI: 0. 85-0. 98), and chronic pancreatitis (P = 1. 48E-02, OR = 0. 91, 95% CI: 0. 84-0. 98). Severe COVID-19 infection was linked to viral hepatitis (P = 3. 57E-02, OR = 1. 00, 95% CI: 1. 00-1. 00), cholelithiasis (P = 3. 50E-02, OR = 1. 00, 95% CI: 1. 00-1. 00), and Crohn’s disease (P = 4. 15E-02, OR = 0. 96, 95% CI: 0. 93-1. 00). Meta-analysis further supported a causal link between COVID-19 and duodenal ulcer (P = 4. 97E-03, OR = 1. 00, 95% CI: 1. 00-1. 00), gastroesophageal reflux disease (P = 3. 38E-02, OR = 1. 04, 95% CI: 1. 00-1. 07), and chronic pancreatitis (P = 2. 67E-03, OR = 0. 92, 95% CI: 0. 87-0. 97). COVID-19 vaccination (Finland) was associated with an increased risk of gastroesophageal reflux disease (P = 3. 38E-02, OR = 1. 12, 95% CI: 1. 01-1. 24). After applying the Benjamini-Hochberg correction, no significant differences were observed in the meta-analysis results. This extensive MR study found no strong causal relationship between COVID-19 infection, vaccination, and 20 common digestive diseases based on genetic data. These results help clarify the longstanding uncertainty surrounding the potential causal links between COVID-19-related factors and digestive diseases. Our findings suggest that genetic variants associated with COVID-19 infection and vaccination do not significantly influence the risk of these diseases, which could inform clinical treatment strategies and public health guidelines.

Open Access PDF

Concepts Keywords
Biobank COVID-19
Coronavirus COVID-19 Vaccines
Finland COVID-19 Vaccines
Longstanding COVID−19
Pancreatitis Digestive diseases
Digestive System Diseases
Finland
Genome-Wide Association Study
Humans
Mendelian randomization
Mendelian Randomization Analysis
Polymorphism, Single Nucleotide
SARS-CoV-2
United Kingdom
Vaccination

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Sequelae
disease MESH infection
disease MESH duodenal ulcer
disease MESH hepatitis
disease MESH cirrhosis
disease MESH chronic pancreatitis
disease MESH cholelithiasis
disease MESH Crohn’s disease
disease MESH gastroesophageal reflux disease
disease MESH uncertainty
disease MESH Long Covid
pathway REACTOME Reproduction
disease MESH severe acute respiratory syndrome
disease MESH virus diseases
disease MESH liver disease
disease MESH pancreatitis
disease MESH lifestyle
disease MESH causality
disease MESH cardiovascular disease
disease MESH cancer
disease MESH critical illness
disease MESH Barrett’s esophagus
disease MESH esophagitis
disease MESH gastric ulcer
disease MESH gastritis
disease MESH gastroduodenal ulcer
disease MESH cholecystitis
disease MESH non alcoholic fatty liver disease
disease MESH irritable bowel syndrome
disease MESH inflammatory bowel disease
pathway KEGG Inflammatory bowel disease
disease MESH colitis
disease MESH appendicitis
drug DRUGBANK L-Phenylalanine
disease IDO host
disease IDO susceptibility
disease IDO process
disease IDO quality
drug DRUGBANK Methionine
disease MESH Digestive System Diseases

Original Article

(Visited 2 times, 1 visits today)